Currently Viewing:
How Has the OCM Evolved? Year 1 Provider Updates
October 24, 2017
Will 2-Sided Risk Be a Reality in OCM?
October 24, 2017
Dr Lucio Gordan: How Practices and Payers Work Together to Implement OCM
October 24, 2017
Dr Jeff Patton Highlights Challenges Encountered With Implementing OCM
October 24, 2017
Physicians Need Clearer Metrics Before Taking on 2-Sided Risk
October 25, 2017
Terrill Jordan: Education and Data Are Key for OCM Success
October 25, 2017
The Commercial Payer OCM Experience: Year 1
October 25, 2017
Stakeholders Weigh-in on Payment Reform in Cancer Care
October 25, 2017
Dr Ira Klein Outlines the Biggest Challenge of Value-Based Drug Pricing
November 05, 2017
Dr Ira Klein on Pharmaceutical Interest in Alternative Payment Models
December 07, 2017
Dr Lucio Gordan: Improving Population Health Through Alternative Payment Models
December 08, 2017
Terrill Jordan: Year 1 Feedback on OCM
December 22, 2017
Sarah Cevallos: Physicians Need More Data to Determine if 2-Sided Risk is Appropriate
December 26, 2017
Terrill Jordan Discusses Making Refinements in Year 2 of OCM
January 03, 2018
Judy Berger on What Southwest Airlines Is Doing in Oncology
January 04, 2018
Currently Reading
Bo Gamble on COA's Role in 2018
January 05, 2018
Dr Roger Brito: What Patients Should Know About Alternative Payment Models, OCM
January 09, 2018
Sarah Cevallos on Her Advice for Practices Looking to Participate in OCM
January 10, 2018
Dr Peter Aran on Involving Providers in Development Process of New Reimbursement Models
January 11, 2018
Dr Jeff Patton Discusses Preparing for OCM, Seeing Improved Outcomes and Savings
January 12, 2018
David Merrill and John Robinson Discuss Barriers to APMs, Factors of Interest
January 15, 2018
Dr Mark Fendrick: Setting Cost-Sharing Based on Value, Not Price, in Cancer Care
January 18, 2018
Terrill Jordan Discusses the Process of Customizing an EMR to Adapt to OCM
January 19, 2018
Dr Roger Brito Discusses Implementing Alternative Payment Models and Its Challenges
January 20, 2018

Bo Gamble on COA's Role in 2018

Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), believes that broadening communication and education is COA’s main goal in 2018. 

Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), believes that broadening communication and education is COA’s main goal in 2018. 


What do you see COA’s role being in the coming year in regard to OCM implementation?

Broaden the communication, broaden the education. Someone gave me a book recently and it’s titled The Speed of Trust and I think it’s very practical, very interesting. It talks about how we change in our society, we’re just not as trustful as we need to be.

I think we need to build the trust component in everything we do. Meaning someone called us one time an honest broker. Give it to COA, an honest broker. That’s a very high compliment, but it also comes with a great deal of responsibility. We need to continue that process. Speak openly, speak honestly, do a little education, and bring people home. I've been with COA for 7 years, with a major cancer care team for 13 years, and doing cancer care for 20 years, and though we’ve been saying the same thing for 5 or 6 years, recently someone who I’ve known for a long time says, "In the sales community you have to say it 6 times before it resonates." So I’m thinking, "okay we need to say it 6 times real fast," but we have to take our time, rearrange our words, say them differently so that it makes sense and it sits with people. And they have that V8 moment like, "wow I need to," and then they’ll implement it. There will be a lot of fault starts but you have to encourage them so they can continue to move forward.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up